Abstract
Classic Kaposi sarcoma (KS) usually is a localized and slowly progressing disease that mainly affects elderly patients; therefore, local treatment generally is recommended. In this study, we evaluated the clinical efficacy of intralesional vinblastine (VNB) for the treatment of classic KS in 6 participants with type 2 diabetes mellitus. Results indicated that intralesional VNB injections may be an effective alternative treatment of classic KS in diabetic patients.
| Original language | English |
|---|---|
| Pages (from-to) | E28-E34 |
| Journal | Cutis |
| Volume | 95 |
| Issue number | 5 |
| Publication status | Published - 2015 |
ASJC Scopus subject areas
- Dermatology
Fingerprint Dive into the research topics of 'Intralesional vinblastine injections for treatment of Classic Kaposi sarcoma in diabetic patients'. Together they form a unique fingerprint.
Cite this
Vassallo, C., Carugno, A., Derlino, F., Ciocca, O., Brazzelli, V., & Borroni, G. (2015). Intralesional vinblastine injections for treatment of Classic Kaposi sarcoma in diabetic patients. Cutis, 95(5), E28-E34.